Aktive Positionen von Priyanka Shah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Investor Relations Kontakt | - | - |
Karriereverlauf von Priyanka Shah
Ehemalige bekannte Positionen von Priyanka Shah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MIRATI THERAPEUTICS | Public Communications Contact | - | 01.04.2022 |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Priyanka Shah
- Erfahrung
